Artificial Intelligence Is Not a Panacea: LungIMPACT Trial Shows Prioritization Cannot Overcome Systemic Delays in Lung Cancer Diagnosis
American Journal of Roentgenology · 17.06.2026
DOI: 10.2214/ajr.26.35373 ↗Kurz gefasst
Kommentar in der Zeitschrift American Journal of Roentgenology, online erschienen am 17.06.2026. Verfasst von Michael A Brooks. Beteiligte Einrichtung: Department of Radiology, University of Kentucky. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Radiology, University of Kentucky.
Zitieren
APA
Brooks, M. A. (2026). Artificial Intelligence Is Not a Panacea: LungIMPACT Trial Shows Prioritization Cannot Overcome Systemic Delays in Lung Cancer Diagnosis. American Journal of Roentgenology. https://doi.org/10.2214/ajr.26.35373
Vancouver
Brooks MA. Artificial Intelligence Is Not a Panacea: LungIMPACT Trial Shows Prioritization Cannot Overcome Systemic Delays in Lung Cancer Diagnosis. American Journal of Roentgenology. 2026. doi:10.2214/ajr.26.35373
BibTeX
@article{Brooks2026,
author = {Brooks, Michael A},
title = {Artificial Intelligence Is Not a Panacea: LungIMPACT Trial Shows Prioritization Cannot Overcome Systemic Delays in Lung Cancer Diagnosis},
journal = {American Journal of Roentgenology},
year = {2026},
doi = {10.2214/ajr.26.35373}
}
EUVIMED